These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11535810)
21. Bak Foong protects dopaminergic neurons against MPTP-induced neurotoxicity by its anti-apoptotic activity. Liu B; Xie JX; Tsang LL; Rowlands DK; Ho LS; Gou YL; Chung YW; Chan HC Cell Biol Int; 2008 Jan; 32(1):86-92. PubMed ID: 17920944 [TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. Zhang D; Anantharam V; Kanthasamy A; Kanthasamy AG J Pharmacol Exp Ther; 2007 Sep; 322(3):913-22. PubMed ID: 17565007 [TBL] [Abstract][Full Text] [Related]
23. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model. Kim NK; Choi BH; Huang X; Snyder BJ; Bukhari S; Kong TH; Park H; Park HC; Park SR; Ha Y Eur J Neurosci; 2009 Mar; 29(5):891-900. PubMed ID: 19245369 [TBL] [Abstract][Full Text] [Related]
24. Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo. Ortiz GG; Crespo-López ME; Morán-Moguel C; García JJ; Reiter RJ; Acuña-Castroviejo D Neuro Endocrinol Lett; 2001 Apr; 22(2):101-8. PubMed ID: 11335886 [TBL] [Abstract][Full Text] [Related]
25. Glia cell number modulates sensitivity to MPTP in mice. Smeyne M; Jiao Y; Shepherd KR; Smeyne RJ Glia; 2005 Nov; 52(2):144-52. PubMed ID: 15920722 [TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effect of arundic acid, an astrocyte-modulating agent, in mouse brain against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity. Himeda T; Kadoguchi N; Kamiyama Y; Kato H; Maegawa H; Araki T Neuropharmacology; 2006 Mar; 50(3):329-44. PubMed ID: 16303147 [TBL] [Abstract][Full Text] [Related]
27. Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF-kappaB in MPTP-treated mice: implication in Parkinson's disease. Karunakaran S; Ravindranath V J Neurochem; 2009 Jun; 109(6):1791-9. PubMed ID: 19457134 [TBL] [Abstract][Full Text] [Related]
28. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325 [TBL] [Abstract][Full Text] [Related]
29. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats. Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221 [TBL] [Abstract][Full Text] [Related]
30. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration. Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381 [TBL] [Abstract][Full Text] [Related]
31. Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice. Mori A; Ohashi S; Nakai M; Moriizumi T; Mitsumoto Y Neurosci Res; 2005 Mar; 51(3):265-74. PubMed ID: 15710490 [TBL] [Abstract][Full Text] [Related]
32. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease. Liu LX; Chen WF; Xie JX; Wong MS Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104 [TBL] [Abstract][Full Text] [Related]
33. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice. Zechel S; Jarosik J; Kiprianova I; Schober A; Unsicker K; von Bohlen und Halbach O Eur J Neurosci; 2006 Mar; 23(6):1671-5. PubMed ID: 16553632 [TBL] [Abstract][Full Text] [Related]
34. Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice. Selley ML Brain Res; 2005 Mar; 1037(1-2):1-6. PubMed ID: 15777746 [TBL] [Abstract][Full Text] [Related]
35. Identification of brain-derived neurotrophic factor in nestin-expressing astroglial cells in the neostriatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Chen LW; Hu HJ; Liu HL; Yung KK; Chan YS Neuroscience; 2004; 126(4):941-53. PubMed ID: 15207328 [TBL] [Abstract][Full Text] [Related]
36. Lamotrigine is neuroprotective in the energy deficiency model of MPTP intoxicated mice. Lagrue E; Chalon S; Bodard S; Saliba E; Gressens P; Castelnau P Pediatr Res; 2007 Jul; 62(1):14-9. PubMed ID: 17515828 [TBL] [Abstract][Full Text] [Related]
37. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835 [TBL] [Abstract][Full Text] [Related]
38. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Jiang H; Li LJ; Wang J; Xie JX Exp Neurol; 2008 Aug; 212(2):532-7. PubMed ID: 18577498 [TBL] [Abstract][Full Text] [Related]
39. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration. Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507 [TBL] [Abstract][Full Text] [Related]
40. [Gene therapy for Parkinson's disease: studies in animal models]. Muramatsu S Rinsho Shinkeigaku; 2001 Dec; 41(12):1157-9. PubMed ID: 12235825 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]